Sponsor Pipeline

Qifeng Zhang Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
3
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-12 NCT07595367
Evaluate the Effectiveness and Safety of BBD-1 Multi-target Immune Enhancement Targeting…		 overall status: Enrolling by Invitation → Recruiting
2026-08-12 NCT07595367
Evaluate the Effectiveness and Safety of BBD-1 Multi-target Immune Enhancement Targeting…		 date change Primary completion pushed: 2028-06-01 -> 2028-08-10
2026-08-12 NCT07595367
Evaluate the Effectiveness and Safety of BBD-1 Multi-target Immune Enhancement Targeting…		 date change Completion pushed: 2028-06-01 -> 2028-08-10
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07595367 Evaluate the Effectiveness and Safety of BBD-1 Multi-target Immune Enhancement Targeting… Allergic Reaction (IgA) Vasculitis Recruiting
Get alerts when Qifeng Zhang's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free